Your shopping cart is currently empty

CP-31398 stabilizes the active conformation of p53 in cancer cells with either mutated or wild-type p53, enhancing its activity. Additionally, CP-31398 upregulates target genes of p53 such as p21WAF1/Cip1 and KILLER/DR5. This compound possesses tumor-suppressive properties.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | CP-31398 stabilizes the active conformation of p53 in cancer cells with either mutated or wild-type p53, enhancing its activity. Additionally, CP-31398 upregulates target genes of p53 such as p21WAF1/Cip1 and KILLER/DR5. This compound possesses tumor-suppressive properties. |
| In vitro | CP-31398, at a concentration of 36.75 μM for 16 hours, induces the expression of p21 in cells with mutated p53. Additionally, CP-31398 administered at 15 μg/mL for 20 hours, promotes apoptosis and arrests the cell cycle in SW480 cells. |
| In vivo | In a xenograft mouse model, CP-31398 (100 mg/kg, orally administered, twice daily for a duration of 7 days) demonstrated significant antitumor activity. |
| Molecular Weight | 362.47 |
| Formula | C22H26N4O |
| Cas No. | 259199-65-0 |
| Smiles | N=1C(=NC(NCCCN(C)C)=C2C=CC=CC12)C=CC3=CC=C(OC)C=C3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.